Cefepime Hydrochloride

盐酸头孢吡肟

Report date: 2023/05/05 17:35:19
NME

Base Information

Drug NameCefepime Hydrochloride
Drug Alias Name头孢平Maxcef头孢匹姆Cefepimi Dihydrochloridum头孢匹美 +[16] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsChronic eosinophilic leukemia (CEL)Complicated Skin and Soft Tissue InfectionsUncomplicated skin and skin structure infections +[44] 
Global Approved IndicationsComplicated Skin and Soft Tissue InfectionsUncomplicated skin and skin structure infectionsFebrile Neutropenia +[10] 
Approved Indications in ChinaComplicated Skin and Soft Tissue InfectionsFebrile NeutropeniaPyelonephritis +[7] 
Original Approved Country/TerritoryN/A
Original Approved Date1993/06/01
Country/TerritoryCzechiaBulgariaUnited States +[17] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesBristol-Myers Squibb SrlVenatorx Pharmaceuticals IncBeni Suef University +[7] 
Inactive CompaniesWake Forest University Health SciencesHospira Inc
Active IndicationsComplicated Skin and Soft Tissue InfectionsFebrile NeutropeniaPregnancy Complications +[11] 
Inactive IndicationsChronic eosinophilic leukemia (CEL)Uncomplicated skin and skin structure infectionsNeutropenia +[33] 

Other Information

ATC CodeJ01DE01
Related LinksWikipediaDrugBankKEGG